Headline News about Bristol-Myers Squibb
What 12 Analyst Ratings Have To Say About Bristol-Myers Squibb
October 20, 2023
Via Benzinga
Via Benzinga
How Is The Market Feeling About Bristol-Myers Squibb?
October 10, 2023
Via Benzinga
Bristol-Myers Squibb Unusual Options Activity For October 06
October 06, 2023
Via Benzinga
FDA Approves Merck's Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication
October 17, 2023
Via Benzinga
Exposures
Product Safety
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|